12Entitlement to botulinum toxin pharmaceutical benefits for treatment of severe primary axillary hyperhidrosis in patient aged 12 years or more, etc

12 Entitlement to botulinum toxin pharmaceutical benefits for treatment of severe primary axillary hyperhidrosis in patient aged 12 years or more, etc

(1) This section applies to eligible patients receiving treatment for severe primary axillary hyperhidrosis if: (a) the patient is aged 12 years or more; and (b) after a period of treatment with topical aluminium chloride hexahydrate: (i) the person demonstrates an intolerance to topical aluminium chloride hexahydrate; or (ii) the person has not responded to the treatment. (2) A person mentioned in subsection (1) is not eligible to receive a botulinum toxin pharmaceutical benefit under this Special Arrangement if the person has been treated with a botulinum toxin pharmaceutical benefit: (a) for 3 treatment periods in the 12 month period preceding the proposed treatment; or (b) in the 4 month period preceding the proposed treatment.